Beyond the standard P&T roster — AI-driven influence mapping reveals hidden advisors, links KOLs to access pathways, and focuses field resources where they matter most.
The Market Access Window Is Short and Decided by People
Market access teams need to know far more than which payer organizations matter. They need to understand who actually influences those payers, what those experts think, and how hidden network relationships shape real-world coverage decisions.
After FDA approval, new therapies are rigorously evaluated by Pharmacy and Therapeutics (P&T) committees, Drug Utilization Review Boards (DURB), pharmacy directors, and medical directors. Standard market access strategies rely on public registries or traditional payer lists to target these obvious decision-makers. However, standard lists present a major strategic blind spot: they omit the unlisted, external advisors who shape those decisions behind closed doors.
The Hidden Influence Gap: Formal P&T and DURB members rarely evaluate complex therapies in a vacuum. Up to 80% of formulary and access decisions are guided by trusted external clinical advisors, academic peers, and health-system influencers whose names never appear on official committee rosters.
What Modern KOL Intelligence Means for Market Access
For Market Access, true KOL intelligence means looking beyond traditional clinical trial leaders. It encompasses the complete ecosystem of decision-makers, the informal experts they consult, and the broader clinical networks that impact treatment access.
This expanded stakeholder map includes:
- Formulary & P&T/DURB Committee Members: The formal voting members and pharmacy directors responsible for institutional reviews.
- Hidden Payer Access Leaders & External Advisors: Unlisted clinical experts, health economists, and external consultants whom P&T chairs trust for guidance.
- Clinical KOLs & Research Collaborators: Top-tier disease experts whose clinical advocacy bridges scientific evidence with formulary approval.
- IDN, CoE, and GPO Leaders: Health system executives shaping protocol design across integrated delivery networks and health systems.
- Patient Advocacy Groups & Pharmacists: Secondary stakeholders amplifying real-world patient needs and comparative value perspectives.
How Ti Expert Delivers Unrivaled Market Access Mapping
- Identify Relevant Payers and Target Accounts
Ti Expert combines patient population data, longitudinal claims, and institutional structure analysis to identify high-priority payer organizations. It maps formal decision-makers within specific Integrated Delivery Networks (IDNs) and P&T/DURB committees, ensuring field efforts target the right accounts.
- Uncover and Map Hidden Influencers
Identifying who holds a voting seat is only half the battle. Ti Expert utilizes advanced AI-driven influence mapping to uncover the unlisted, less-visible external advisors who actively advise P&T members and health system leaders.
By analyzing multi-layered data—including co-authorships, speaking engagements, joint clinical trials, advisory board histories, research grants, and institutional affiliations—Ti Expert reveals hidden consensus networks. This allows access teams to see precisely which external advisors hold sway over targeted IDN and payer committees.
- Bridge Clinical KOLs directly to Payer Decision-Makers
A primary challenge for biopharma is operating in silos: Medical Affairs manages clinical KOLs, while Market Access focuses on payer accounts. Ti Expert bridges this gap. It maps how your existing clinical KOL relationships connect directly to key advisors and payer decision-makers, enabling teams to convert clinical reputation into tangible access leverage.
- Optimize Field Resource Allocation
Equipped with comprehensive network intelligence, account teams no longer waste time on broad, generic outreach. Ti Expert allows Market Access leads to direct field resources precisely toward the specific high-leverage relationships that drive favorable formulary placement and speed up market adoption.
- Understand Expert Sentiment and Competitive Relationships
Two experts may hold identical titles yet possess vastly different perspectives on your therapy. Ti Expert measures stakeholder sentiment around your product and tracks competitor ties (such as ongoing consulting contracts, speaking engagements, and research funding), answering critical strategic questions: Who will champion our product, and where do competitive strongholds exist?
Stay Current Through the Launch Window with NotifyMe
The market access landscape evolves rapidly. An advisor may transition to a key health system, sentiment may shift following new clinical data, or a competitor may expand its advisor footprint. Ti Expert’s NotifyMe feature delivers human-in-the-loop intelligence, combining AI screening with review by trained Medical Analysts to deliver actionable, validated alerts straight to your team.
Built-in Compliance & Firewall Architecture
Market Access, Medical Affairs, and Commercial teams often interact with overlapping expert communities. Ti Expert’s compliant firewall architecture provides a unified organizational view of the stakeholder landscape while maintaining strict boundaries around regulatory compliance and functional role access.
Market Access Intelligence Capabilities Checklist
Capability | Question It Answers | Ti Expert Differentiator |
Payer Identification | Which payer organizations and IDNs matter most? | Claims and patient population analysis |
Decision-Maker Mapping | Who holds the formal P&T / DURB review seats? | Formulary decision-maker identification |
Hidden Influencer Mapping | Who are the unlisted advisors guiding decision-makers? | AI network mapping & connection analysis |
Clinical-to-Access Bridge | How do our clinical KOLs connect to payer networks? | Cross-functional network link mapping |
Field Resource Optimization | Which specific relationships drive formulary placement? | Key account influence profiling |
Advocate & Sentiment Intel | Who supports us and where are competitor ties? | Sentiment scoring & competitive tracking |
Ongoing Monitoring | What critical changes occurred across our target accounts? | NotifyMe expert-reviewed alerts |
Compliance & Firewalls | Can teams collaborate while respecting compliance rules? | Built-in compliance firewall architecture |
Frequently Asked Questions (FAQs)
- What is KOL intelligence in Market Access?
It is a modern, data-driven approach that maps not only formal institutional decision-makers but also the extended network of external advisors, clinical experts, and influencers who shape coverage outcomes.
- How do you identify influencers who aren’t listed on official P&T roster sheets?
Ti Expert uses AI algorithms to analyze shared publications, clinical trial co-authorships, grant histories, speaking panels, and consulting engagements. This surfaces the hidden advisors in your TA whom P&T chairs and medical directors consult prior to formulary votes.
- Who influences formulary decisions besides P&T committee chairs?
Formulary decisions are heavily influenced by unlisted external advisors, clinical KOLs, DURB members, health economists, pharmacy directors, and key opinion leaders within specific Integrated Delivery Networks (IDNs).
- How does bridging Clinical KOLs with Access teams improve outcomes?
Clinical KOLs provide the scientific context and real-world clinical experience that payer decision-makers rely on. Bridging these networks allows access teams to leverage existing clinical relationships to support evidence presentation during formulary reviews.
- When should Market Access teams begin influencer mapping?
Well before launch. Mapping decision-makers and their influence networks during phase 2/3 clinical development gives market access and account teams sufficient runway to build targeted, compliant engagement strategies.
The Takeaway
Market access decisions involve much more than institution lists and static formularies. They involve human relationships, hidden networks, and trust. By looking beyond traditional P&T rosters to uncover hidden influencers, Market Access teams can align field resources, leverage clinical network insights, and secure faster, broader coverage.
Ready to uncover the hidden influencers in your key accounts?
Book a demo at https://neolytica.ai/contact/ or explore our capabilities at https://neolytica.ai/market-access/